SPRIM
VC Fund
Bengaluru, India
SPRIM is a management consulting company with a venture capital division, known as SPRIM Ventures.
- Total investments:
- 5
- Last investment:
- Lead investor:
- 60%
Last updated:
For AI agents: llms.txt
Industries SPRIM invests in
Health CareBiotechnologyService IndustryHealth Diagnostics
Stages SPRIM invests in
Series ASeedSeries B
Countries SPRIM invests in
United StatesSingapore
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Investment Focus
Industry
- Health Care 2 (40%)
- Biotechnology 1 (20%)
- Service Industry 1 (20%)
- Health Diagnostics 1 (20%)
Stage
- Series A 3 (60%)
- Seed 1 (20%)
- Series B 1 (20%)
Country
- United States 2 (40%)
- Singapore 1 (20%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Dan Brenner
Chief Growth Officer
|
Chief Growth Officer | Total investments: 0 | Find email | |
Ivan Jarry
Co-Founder & Managing Partner
|
Co-Founder & Managing Partner | Total investments: 0 | Find email | |
Michael Shleifer
Managing Partner & Co-Founder
|
Managing Partner & Co-Founder | Total investments: 4 | Find email | |
Olivier Shleifer
Co-Founder & Managing Partner
|
Co-Founder & Managing Partner | Total investments: 0 | Find email | |
|
Rodney Cheung
CIO
|
CIO | Total investments: 0 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
|
Mi-Helper
|
Mi-Helper helps to develop a non-drug remedy for migraine and mood issues. | $4M / Series A / Oct 10, 2022 | |
AUM Biosciences
|
AUM Biosciences is an oncology-focused biotechnology company that aims to accelerate the development of innovative, affordable medicines for patients in Asia and around the world. AUM Biosciences focuses on early-stage development of innovative medicines for the treatment of Asian-prevalent cancers. | $27M / Series A / Oct 12, 2021 | |
ObvioHealth
|
ObvioHealth is a global digital health organization providing real-world digital clinical trials that deliver better data.Our mobile clinical study application allows for site-less trial design, allowing subjects to use their smartphones to participate in remote monitoring clinical trials from the comfort of their homes. For studies designed toinclude site visits, our application allows for continuous data collection in between visits to the clinic.By bringing the trial directly to the mobile device of each participant, our study team engages subjects daily using text message and chatbot features. This interaction allows for open communication and helps subjects feel involved during virtual clinical trials.The result: robust data collection, increased compliance, faster recruitment and improved time to completion.To assist with collecting real world data in clinical trials, our app can easy link to various health devices. They include Apple watches, Fitbits and activity trackers, along with Bluetooth scales, blood pressure monitors, and smart health apps.Participants can also use the app to schedule lab visits, or connect it with their PayPal account to receive compensation for decentralized clinical trials. And if the study team needs to talk with the participant during mobile clinical trials, the app allows for easy communication through chat or video.Visit Obviohealth.com to learn more about how our technology can help with observational clinical trials and virtual clinical trials. | $19.3M / Series B / Jun 08, 2021 | |
|
ObvioHealth
|
ObvioHealth is a global digital health organization providing real-world digital clinical trials that deliver better data.Our mobile clinical study application allows for site-less trial design, allowing subjects to use their smartphones to participate in remote monitoring clinical trials from the comfort of their homes. For studies designed toinclude site visits, our application allows for continuous data collection in between visits to the clinic.By bringing the trial directly to the mobile device of each participant, our study team engages subjects daily using text message and chatbot features. This interaction allows for open communication and helps subjects feel involved during virtual clinical trials.The result: robust data collection, increased compliance, faster recruitment and improved time to completion.To assist with collecting real world data in clinical trials, our app can easy link to various health devices. They include Apple watches, Fitbits and activity trackers, along with Bluetooth scales, blood pressure monitors, and smart health apps.Participants can also use the app to schedule lab visits, or connect it with their PayPal account to receive compensation for decentralized clinical trials. And if the study team needs to talk with the participant during mobile clinical trials, the app allows for easy communication through chat or video.Visit Obviohealth.com to learn more about how our technology can help with observational clinical trials and virtual clinical trials. | $17M / Series A / Apr 14, 2020 | |
|
ObvioHealth
|
ObvioHealth is a global digital health organization providing real-world digital clinical trials that deliver better data.Our mobile clinical study application allows for site-less trial design, allowing subjects to use their smartphones to participate in remote monitoring clinical trials from the comfort of their homes. For studies designed toinclude site visits, our application allows for continuous data collection in between visits to the clinic.By bringing the trial directly to the mobile device of each participant, our study team engages subjects daily using text message and chatbot features. This interaction allows for open communication and helps subjects feel involved during virtual clinical trials.The result: robust data collection, increased compliance, faster recruitment and improved time to completion.To assist with collecting real world data in clinical trials, our app can easy link to various health devices. They include Apple watches, Fitbits and activity trackers, along with Bluetooth scales, blood pressure monitors, and smart health apps.Participants can also use the app to schedule lab visits, or connect it with their PayPal account to receive compensation for decentralized clinical trials. And if the study team needs to talk with the participant during mobile clinical trials, the app allows for easy communication through chat or video.Visit Obviohealth.com to learn more about how our technology can help with observational clinical trials and virtual clinical trials. | $6M / Seed / Mar 23, 2018 |
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Similar country
Featured in Investor Lists
Recommended lists
Health Care Investors
43,014 investors
Biotech Investors
21,775 investors
Biotechnology Investors
19,370 investors
Health Care VC Funds
32,370 investors
Biotech VC Funds
18,864 investors
Biotechnology VC Funds
17,016 investors
Health Care Investors in United States
21,541 investors
Biotech Investors in United States
11,011 investors
Biotechnology Angel Investors
2,354 investors
FAQ
What does SPRIM invest in?
SPRIM invests primarily in Health Care, Biotechnology and Service Industry startups, most often at Series A and Seed stage. Most of the 5 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact SPRIM?
Public channels for SPRIM include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at SPRIM?
The team at SPRIM includes Dan Brenner (Chief Growth Officer), Ivan Jarry (Co-Founder & Managing Partner) and Michael Shleifer (Managing Partner & Co-Founder). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
